Sonya Erickson

Sonya Erickson is a partner in Cooley’s Emerging Companies and Life Sciences practice groups and a member of the Firm’s Business department. She joined the Firm in 2008 and is resident in the Seattle office. Ms. Erickson’s practice encompasses the representation of emerging growth companies, established technology businesses and venture capital funds. Ms. Erickson has represented issuers and underwriters in numerous public offerings, has substantial experience in venture capital and other private financing transactions and has worked on technology-based strategic partnerships, collaborations and mergers and acquisitions. In addition, Ms. Erickson is corporate counsel for numerous private and public companies including Alder Biopharmaceuticals, Inc., ARZEDA Corporation, Blue Nile, Inc. (NILE), EKOS Corporation, EndoGastric Solutions, Inc., Ground Truth, Inc., Seattle Genetics, Inc. (SGEN), Varolii Corporation, and Zumobi, Inc.